Today the SEC announced final rules concerning compensation committees of public company boards of directors. This action is a mere two years after being mandated by the Dodd Frank Act and demonstrates the struggles of the SEC in keeping up … Continue reading
Category Archives: The Law
At the May meeting of the New England Chapter of the National Association for Corporate Directors, the subject was that time-honored question: “what keeps the directors up at night?” As it turns out, an awful lot. A spirited panel included … Continue reading
On a recent visit to Boston, Attorney Steve Shapiro (General Counsel to the American Civil Liberties Union) outlined matters before the Supreme Court today, or likely to arise in the coming 2012-2013 session. I. Obama – Care The gorilla in the … Continue reading
The other day at UMass Boston, MassMEDIC (the trade organization of Massachusetts medical device companies) held its 16th Annual Conference. It was well attended, and my prior blog post reported Covidien CEO Jose Almeida’s comments for the advancement of the United … Continue reading
In conjunction with Mass MEDIC’s 16th Annual Conference, Jose Almeida, who is chairman and president and CEO of Covidien, today put forward a roadmap for what has to be done to retain the United States’ primacy in the medical device field. … Continue reading
At the April Breakfast Meeting of the New England Chapter of the National Association of Corporate Directors, a panel of public company directors faced “the Enemy” in the person of Pat McGurn, who represents the ISS. For the uninitiated, ISS … Continue reading
Jeffrey Toobin’s lead article in the April 9 New Yorker is a clear and convincing argument for the liberal viewpoint on the Supreme Court’s role in evaluating Romneycare – whoops, I mean Obamacare. As befits a graduate of THE Law … Continue reading
The Massachusetts Biotechnology Council meeting on The Business of Science concluded March 27, as it began: lots of discussion of the technology, interspersed with programs about the business and financial aspects of bio which all had the same themes: bio … Continue reading
Ernie Godshalk is a professional director currently sitting on two public boards; a director of the National Association of Corporate Directors/New England, Ernie is well known to the local director community as a thoughtful commentator on board service. His current view … Continue reading
The Massachusetts Biotechnology Council’s program entitled “2012 Annual Meeting – the Business of Science” is underway, and the kick-off keynote speech and first panel spent a good deal of time exploring why the business approach to funding bio is not … Continue reading